Cocaine Addiction Clinical Trial
Official title:
A Pilot Study of Deep Brain Stimulation of the Sub-thalamic Nucleus to Treat Treatment-resistant Cocaine Addiction With Severe Somatic or Psychiatric Complications
Cocaine addiction is a chronic condition with severe cardiac, neurologic, psychiatric and
social complications. Cocaine is the second most consumed illicit drug in France. Its
prevalence has been multiplied by 3 between 2000 and 2008, and is still on the rise.
Craving, the compulsive need to consume, is a key feature of cocaine addiction. It is also
predictive of treatment efficacy. However, there is no validated treatment for severe
cocaine dependence yet. Response to current psychological and medical treatment is poor,
with 73% relapse after 3 months. Patients with severe cocaine addiction are thus in a
therapeutic deadlock.
To address these unmet medical needs, the investigators designed a pilot study (n=2) to
evaluate the safety and the efficacy of the deep brain stimulation of the subthalamic nuclei
(STN-DBS) in severe cocaine addiction with at least one cardiac, neurologic or psychiatric
complication. Indeed, compulsivity is a critical component of craving, and severe
treatment-resistant obsessive compulsive disorder (OCD) are already successfully treated
using STN-DBS. Moreover, animal studies recently demonstrated a therapeutic effect of
STN-DBS in rats addicted to cocaine. Together, these two lines of research suggest a
therapeutic effect of STN-DBS in cocaine addiction mediated by an anti-obsessive mechanism
on craving.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04336293 -
sTMS for Substance Use-disordered Veterans
|
N/A | |
Completed |
NCT02939352 -
The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues
|
Early Phase 1 | |
Completed |
NCT01822587 -
Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving
|
Phase 2 | |
Completed |
NCT01601743 -
Exercise as a Behavioral Treatment for Cocaine Dependence
|
N/A | |
Completed |
NCT02563769 -
Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study
|
Phase 1 | |
Completed |
NCT01651377 -
Pramipexole as a Treatment for Cocaine Dependence
|
Phase 1 | |
Completed |
NCT02768441 -
Dexamphetamine Sustained Release Pharmacokinetics and Clinical Validation of Dried Blood Spots
|
Early Phase 1 | |
Completed |
NCT02626494 -
Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction
|
Phase 4 | |
Not yet recruiting |
NCT01319214 -
Reducing Drug Craving Memories
|
N/A | |
Recruiting |
NCT01259362 -
Effects of Repeated Transcranial Magnetic Stimulation (rTMS) on the Treatment of Cocaine Addicted Patients
|
Phase 2 | |
Completed |
NCT01211418 -
Integrative Meditation (IM) for Cocaine Addiction
|
N/A | |
Recruiting |
NCT03423667 -
Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients With Cocaine Addiction
|
Phase 2 | |
Completed |
NCT01984177 -
Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence
|
N/A | |
Completed |
NCT01887366 -
Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects
|
Phase 2 | |
Completed |
NCT01337297 -
Prefrontal Cortex Stimulation as Treatment for Crack-cocaine Addiction
|
Phase 1/Phase 2 | |
Completed |
NCT01067846 -
Cognitive Enhancement and Relapse Prevention in Cocaine Addiction
|
N/A | |
Completed |
NCT01651364 -
A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence
|
Phase 1 | |
Recruiting |
NCT03018236 -
Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.
|
Phase 4 | |
Completed |
NCT01929343 -
Lidocaine Infusion as a Treatment for Cocaine Relapse and Craving
|
Phase 2 | |
Completed |
NCT01281202 -
Vigabatrin for the Treatment of Cocaine Dependency
|
Phase 2/Phase 3 |